An innovative diagnostic strategy for the detection of rare molecular targets to select cancer patients for tumor-agnostic treatments

Targeted therapies are playing an increasing role in oncology. Among them, particular attention is nowadays reserved to histology-agnostic treatments. Rare molecular alterations affecting different neoplastic forms, such as Microsatellite Instability (MSI), Neurotropic Tyrosine Receptor Kinase (NTRK...

Descripción completa

Detalles Bibliográficos
Autores principales: Marchetti, Antonio, Di Lorito, Alessia, Felicioni, Lara, Buttitta, Fiamma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916754/
https://www.ncbi.nlm.nih.gov/pubmed/31857850
http://dx.doi.org/10.18632/oncotarget.27343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916754/
https://www.ncbi.nlm.nih.gov/pubmed/31857850
http://dx.doi.org/10.18632/oncotarget.27343

Ejemplares similares